Dr Tariq's scientific publications and conference presentations

Publication details

 

1. Jagmag T, Tirant M, Lotti  T.  Link between cutaneous infection, stress and depression.  J Biol Regul Homeost Agents. 2017;31(4):1037-1041. (Direct link to the article :  https://pubmed.ncbi.nlm.nih.gov/29254311/ )

2. Sreevallabhan S, Mohanan R, Sukumaran S, Sobha A P, Jose S P, Sukumarpillai A, Jagmag T, Tilwani J. Ameliorating effect of glutathione- enriched herbal formulation (glothione) on alloxan-induced experimental diabetic model by modulating oxidative stress and pathogenesis. J Food Biochem. 2020; 00: e13153. (Direct link to the article :  https://onlinelibrary.wiley.com/doi/abs/10.1111/jfbc.13153 )

3. Ratheesh M, Sheethal S, Svenia P. Jose, Sony Rajan, Sulumol Thomas, Tariq Jagmag & Jayesh Tilwani(2020) Biochemical and immunological aspects of COVID-19 infection and therapeutical intervention of oral low dose cytokine therapy: a systematic review. Immunopharmacology and Immunotoxicology,  DOI: 1080/08923973.2020.1842444. (Direct link to the article : https://www.tandfonline.com/doi/full/10.1080/08923973.2020.1842444 )

4. Sreevallabhan S, Mohanan R, Jose SP, Sukumaran S, Jagmag T, Tilwani J, Kulkarni A.    Hepatoprotective effect of essential phospholipids enriched with virgin coconut oil (Phoscoliv) on paracetamol induced liver toxicity. J Food Biochem. 2021;00:e13606. (Direct link to the article :  https://doi.org/10.1111/jfbc.13606)

5. Ratheesh, M., Sunil, S., Sheethal, S. Jose S, Sandya S, Ghosh OSN, Rajan S, Jagmag T, Tilwani J. Anti-inflammatory and antiCOVID-19 effect of a novel polyherbal formulation (Imusil) via modulating oxidative stress, inflammatory mediators and cytokine storm. Inflammopharmacol 30, 173–184 (2022). (Direct link to the article https://pubmed.ncbi.nlm.nih.gov/35075553/)

Conference presentations

 

1.Invited speaker on the topic of “Treating resistant chronic infections with calium EDTA: case presentation” at International Nutritional and Environment medicine conference – Jun 2017, Cochin, India.

2. Poster presentation at 2019 FOCIS Asian Advanced Course in Basic & Clinical Immunology

1) Effect of low dose interferon beta and essential phospholipids in patients with atherosclerosis  and mild hypertension
2) Low dose interleukin 10 and anti interleukin 1 in treatment of endometrial hyperplasia and  rheumatoid arthritis

3. Invited speaker on the topic of “Low dose cytokines, homeopathic and phytomedicine in infections” at International conference on Homeopathy and Phytomedicine – Jan 2020, St Thomas college, Pala, India

4. Invited speaker on the topic “Cytokine milieu in COVID-19 and its management” at Malaysian Association of Advancement of Functional and          Interdisciplinary Medicine (MAAFIM) virtual conference : COVID-19 summit held from 10-11 Apr 2021. Watch in here.

5. Poster presentation on “Cytokine Milieu in COVID-19 and therapeutical interventions of oral low dose cytokine therapy” at 21st annual meeting of the Federation of Clinical Immunology Societies (FOCIS 2021 vitual conference from 8-11 Jun 2021).

6. Invited speaker on the topic of “Long COVID” by Healing our Earth platform on 12 Dec 2021.

7. Invited speaker on the topic of “Long COVID” by World Council for Health platform on 22 Dec 2021. Watch it here.

8. Invited speaker on 7th Annual Nutrition Summit, Mumbai, India on 28-29 Apr 2022 on topic “Anti-inflammatory, antiviral, antioxidant properties of Imusil which enables it to treat Covid, Long Covid and reduces belly fat too”.

9. Invited for panel discussion on 7th Annual Nutrition Summit, Mumbai, India on 28-29 Apr 2022 on topic “Obesity and weight management: Nutraceuticals in endocrine and metabolic disorders”.

10. Invited speaker at International Conference on Clinical Nutrition & Dietary Lifestyle 20-21 May 2022 at Bangalore, India on topic “Anti-inflammatory and anti covid effects of a novel polyherbal formulation (imusil) via modulating oxidative stress, inflammatory mediators and cytokine storms”.

11. Speaker at the 8th International Conference on Public Health – “Impact of Covid-19 Pandemic on Public Health, Economy and
the Government Sector: Tackling the Present and Shaping the Future” on topic “Novel polyherbal formulation (Imusil) as an anti-inflammatory and antiviral against COVID, 28-29 July 2022.

 

 

1) Biochemical and immunological aspects of COVID-19 infection and therapeutically intervention of oral low dose cytokine therapy

2) FOCIS poster Mar 2019 Effect of low dose interferon beta and essential phospholipids in patients with atherosclerosis and mild hypertension

3) FOCIS poster Mar 2019 Low dose interleukin 10 and anti interleukin 1 in treatment of endometrial hyperplasia and rheumatoid arthritis

4) Ameliorating effect of glutathione

5) Hepatoprotective effect of essential phospholipids enriched with virgin coconut oil (Phoscoliv) on paracetamol induced liver toxicity.

6) FOCIS poster Jun 2021 on “Cytokine milieu in COVID-19 and therapeutical intervention of oral low dose cytokine therapy”

Publications